4000-520-616
欢迎来到免疫在线!(蚂蚁淘生物旗下平台)  请登录 |  免费注册 |  询价篮
主营:常规产品包括:丝氨酸蛋白酶、蛋白酶抑制剂、中性粒细胞酶、载脂蛋白、脂蛋白,血小板蛋白、转铁蛋白、免疫球蛋白
咨询热线电话
4000-520-616
当前位置: 首页 > 产品中心 > peptide > 雅典研究院/坎比奥-卓越分子生物学/100µ摩尔/10-1041-90
商品详细雅典研究院/坎比奥-卓越分子生物学/100µ摩尔/10-1041-90
雅典研究院/坎比奥-卓越分子生物学/100µ摩尔/10-1041-90
雅典研究院/坎比奥-卓越分子生物学/100µ摩尔/10-1041-90
商品编号: 10-1041-90
市场价: ¥0.00
美元价: 0.00
产地: 美国(厂家直采)
公司:
产品分类: 多肽合成
公司分类: peptide
联系Q Q: 3392242852
电话号码: 4000-520-616
电子邮箱: info@ebiomall.com
商品介绍
Oligo Synthesis

Oligo Synthesis : CEPs

Prices quoted are for single packs only. For multiples of the same product please request a quote. Some of Glen"sproductsarehazardousandmay be subject to additional shipping charges. Full product information is available onGlen Research"s website.

  • Catalogue
  • Description
  • Protocols
  • Applications & Benefits

2"-DeoxyNebularine-CE Phosphoramidite (Purine)

2"-DeoxyNebularine-CE Phosphoramidite (Purine)

Glen Research

Catalogue No.DescriptionPack SizePriceQty
  • Change to:
  • €
10-1041-022"-DeoxyNebularine-CE Phosphoramidite (Purine)0.25g£204.00£193.80Offer until : 31-Mar-2021Offer Code : GLEN55% off all Glen productsView OfferQuantityAdd to Order
10-1041-902"-DeoxyNebularine-CE Phosphoramidite (Purine)100µmoles£84.00£79.80Offer until : 31-Mar-2021Offer Code : GLEN55% off all Glen productsView OfferQuantityAdd to Order

2"-DeoxyNebularine-CE Phosphoramidite (Purine)

2"-DeoxyNebularine-CE Phosphoramidite (Purine)

Glen Research

2"-DeoxyNebularine-CE Phosphoramidite (Purine)

Structure

Catalog Number: 10-1041-xx

Description: 2"-DeoxyNebularine-CE Phosphoramidite (Purine)

5"-Dimethoxytrityl-2"-deoxyNebularine,3"-[(2-cyanoethyl)-(N,N-diisopropyl)]-phosphoramidite
Formula: C40H47N6O6PM.W.: 738.82F.W.: 298.19

Diluent: Anhydrous Acetonitrile
Coupling: No changes needed from standard method recommended by synthesizer manufacturer.
Deprotection: No changes needed from standard method recommended by synthesizer manufacturer.
Storage: Refrigerated storage, maximum of 2-8°C, dry
Stability in Solution: 24 hours

duplex effects

The design of primers is frequently complicated by the degeneracy of the genetic code. Three strategies are now available to confront this problem. In the first, a mixed base addition (N) is used to form the degenerate site. This approach is best if the number of degenerate sites is small. A second option is the use of 2’-deoxyInosine or 2’-deoxyNebularine which exhibit low, but unequal, hydrogen bonding to the other four bases. The third option is the use of a universal nucleoside. In this strategy, the base analog does not hybridize significantly to the other four bases and makes up some of the duplex destabilization by acting as an intercalating agent. 3-Nitropyrrole 2’-deoxynucleoside (M) is the first example of a set of universal bases. Subsequently, 5-nitroindole was determined to be an effective universal base and to be superior to 3-nitropyrrole, based on duplex melting experiments.

The modified bases designated P and K show considerable promise as degenerate bases. The pyrimidine derivative P, when introduced into oligonucleotides, base pairs with either A or G, while the purine derivative K base pairs with either C or T. A dP dK mix also can serve as a mixed base with much less degeneracy than dA dC dG dT (N).

If you cannot find the answer to your problem below then please contact us or telephone 01954 210 200

2"-DeoxyNebularine-CE Phosphoramidite (Purine)

2"-DeoxyNebularine-CE Phosphoramidite (Purine)

Glen Research

MSDS

If you cannot find the answer to your problem below then please contact us or telephone 01954 210 200

2"-DeoxyNebularine-CE Phosphoramidite (Purine)

2"-DeoxyNebularine-CE Phosphoramidite (Purine)

Glen Research

The design of primers is frequently complicated by the degeneracy of the genetic code. Three strategies are now available to confront this problem.

  1. A mixed base addition (N) is used to form the degenerate site. This approach is best if the number of degenerate sites is small.
  2. The use of 2"-deoxyInosine or 2"-deoxyNebularine which exhibit low, but unequal, hydrogen bonding to the other 4 bases.
  3. The use of a universal nucleotide. In this strategy, the base analog does not hybridise significantly to the other 4 bases and makes up some of the duplex destabilisation by acting as an intercalating agent.

EXTINCTION DATA

ItemNucleosideλMax-1Emax-1λMax-2Emax-2E260
(nm)(ml/µmole)nm(ml/µmole)(ml/µmole)
10-1041dNebularine262 17.17

DILUTION/COUPLING DATA

The table below shows pack size data and, for solutions, dilutions and approximate couplings based on normal priming procedures

ABI 392/394
Cat.No.PackSizeGrams/Pack0.1M Dil.(mL)LV40LV20040nm0.2µm1µm10µm
Approximate Number of Additions
10-1041-020.25grams.25grams3.3899.3359.637.2527.0919.874.97
10-1041-90100µmoles.074grams120127.55.4541
Expedite
Cat.No.PackSizeGrams/PackDilution(mL)Molarity50nm0.2µm1µm15µm
Approximate Number of Additions
10-1041-020.25grams.25grams5.05.0794.659.13435.91
10-1041-90100µmoles.074grams1.5.0723.614.7510.731.48
Beckman
Cat.No.PackSizeGrams/PackDilution(mL)Molarity30nm200nm1000nm
Approximate Number of Additions
10-1041-020.25grams.25grams5.05.0796.260.1343.73
10-1041-90100µmoles.074grams1.5.0725.215.7511.45

If you cannot find the answer to your problem below then please contact us or telephone 01954 210 200

品牌介绍
Athens Research & Technology—供应多款蛋白、酶制品 Athens Research & Technology是成立于2010年的新兴生物高科技制品公司,该公司拥有BSL-2实验室及超过11000平方英尺的cGMP生产厂房,并且通过ISO 9001:2008认证。Athens公司致力于纯化分离高纯度,高活性的人类蛋白质及研发多克隆抗血清产品。提供包括高纯度及活性的丝氨酸蛋白酶,蛋白酶抑制剂,中性粒细胞酶,载脂蛋白,脂蛋白,血小板蛋白,转铁蛋白,免疫球蛋白等等。公司产品适用于炎症,冠状动脉疾病,自身免疫性疾病,癌症,阿尔茨海默氏病等众多研究领域,已被世界*制药公司及诊断试剂公司用于体外诊断试剂盒/免疫检测试剂盒、药物筛选、细胞培养液(包括干细胞)等产品研发。除了人类蛋白质,我们还从动物血清和组织中分离多种蛋白质及酶类。此外,Athens Research and Technology还提供特殊试剂/蛋白定制服务,以满足研究人员的不同需求。